Plasmodium Vivax Malaria Clinical Trials
3 recruiting trials for Plasmodium Vivax Malaria. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
1
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 4NCT05788094
ACT vs CQ With Tafenoquine for P. Vivax Mono-infection
In this area of Greater Mekong Subregion (GMS), vivax malaria is the most common kind of malaria. It can stay very long in the liver, and come out later to make another episode of...
Sponsor: Shoklo Malaria Research UnitEnrolling: 6061 location
RECRUITINGPhase 4NCT04704999
Southeast Asia Dose Optimization of Tafenoquine
Tafenoquine was recently approved by regulatory authorities in the USA and Australia. Tafenoquine is an alternative radical curative treatment to primaquine acting against the...
Sponsor: University of OxfordEnrolling: 7005 locations
RECRUITINGPhase 3NCT05690841
FocaL Mass Drug Administration for Vivax Malaria Elimination
FLAME is an open-label cluster-randomized controlled trial that aims to determine the effectiveness of focal mass drug administration (fMDA) to reduce the incidence of Plasmodium...
Sponsor: University of California, San FranciscoEnrolling: 75301 location